1. Home
  2. PTON vs KLRA Comparison

PTON vs KLRA Comparison

Compare PTON & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peloton Interactive Inc.

PTON

Peloton Interactive Inc.

HOLD

Current Price

$4.95

Market Cap

2.4B

ML Signal

HOLD

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$13.94

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PTON
KLRA
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
PTON
KLRA
Price
$4.95
$13.94
Analyst Decision
Buy
Analyst Count
11
0
Target Price
$7.89
N/A
AVG Volume (30 Days)
7.1M
745.2K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
146.67
N/A
EPS
0.14
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.44
N/A
P/E Ratio
$36.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.65
$14.76
52 Week High
$9.20
$23.82

Technical Indicators

Market Signals
Indicator
PTON
KLRA
Relative Strength Index (RSI) 36.67 35.61
Support Level $4.44 N/A
Resistance Level $6.00 $19.02
Average True Range (ATR) 0.17 1.22
MACD -0.02 -0.16
Stochastic Oscillator 0.77 7.03

Price Performance

Historical Comparison
PTON
KLRA

About PTON Peloton Interactive Inc.

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Products derive revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: